Mark Elwood

9PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingMolecular targetsPacific Peoples health policyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 11, 2025
Statin use and breast cancer-specific mortality and recurrence: a systematic review and meta-analysis including the role of immortal time bias and tumour characteristics.

Oliver William Scott, Sandar Tin Tin, Alana Cavadino

|Mar 03, 2025
Treatment Outcomes From Erlotinib and Gefitinib in Advanced Epidermal Growth Factor Receptor-Mutated Nonsquamous Non-Small Cell Lung Cancer in Aotearoa New Zealand From 2010 to 2020: Nationwide Whole-of-Patient-Population Retrospective Cohort Study.

Phyu Sin Aye, Joanne Barnes, George Laking

|Jul 02, 2024
Erlotinib or Gefitinib for Treating Advanced Epidermal Growth Factor Receptor Mutation-Positive Lung Cancer in Aotearoa New Zealand: Protocol for a National Whole-of-Patient-Population Retrospective Cohort Study and Results of a Validation Substudy.

Phyu Sin Aye, Joanne Barnes, George Laking

|Mar 03, 2022
Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study.

Citadel J Cabasag, Melina Arnold, Mark Rutherford

|Jan 24, 2019
Rapid increase in endometrial cancer incidence and ethnic differences in New Zealand.

Oliver W Scott, Sandar Tin Tin, Susan M Bigby

|Sep 19, 2018
Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.

J Mark Elwood, Essa Tawfiq, Sandar TinTin

Pageof 2

Frequent Collaborators

4 joint publications

Sandar Tin Tin

2 joint publications

Mark James McKeage

2 joint publications

Oliver William Scott

2 joint publications

Dean Harris